Precision Medicine

Whole genome and exome sequencing identify disease-associated variants. Liquid biopsy tracks tumor evolution through blood draws. Pharmacogenomic testing predicts drug response based on genetic variants. AI integrates multi-omic data for treatment recommendations. Clinical decision support presents genomic findings in actionable formats for physicians.

Oncology: tumor genomic profiling guides selection of targeted therapies. Pharmacogenomics: genetic testing determines optimal antidepressant selection. Rare disease: whole genome sequencing identifies causative mutations. Cardiology: genetic risk scores predict cardiovascular disease risk.

Precision medicine tailors treatment to individual patient characteristics using genomic, biomarker, and clinical data. With 1 funder. The convergence of genomics, AI, and clinical medicine is making personalized treatment the standard of care.